Guided Therapeutics Inc (GTHP) stock
GTHPOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$0.16−0.03 (-15.79%)
Close on Oct 19, 2026Market cap $15.45MP/E –Yield –
Guided Therapeutics r&d expenses
Research and development expenses are spending on new products and technology.
Guided Therapeutics's R&D Expenses for the twelve months ending Jun 30, 2026 was $342.00K, down 25.3% year over year. For fiscal 2025 it was $469.00K, down 10.8% from the year before. Over ten years it grew -10.8% a year on average. The highest annual figure on record is $3.23M in fiscal 2012.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $469.00K | -10.8% |
| FY2024 | Dec 31, 2024 | $526.00K | +130.7% |
| FY2023 | Dec 31, 2023 | $228.00K | +196.1% |
| FY2022 | Dec 31, 2022 | $77.00K | +11.6% |
| FY2021 | Dec 31, 2021 | $69.00K | -51.7% |
| FY2020 | Dec 31, 2020 | $143.00K | +17.2% |
| FY2019 | Dec 31, 2019 | $122.00K | -50.0% |
| FY2018 | Dec 31, 2018 | $244.00K | -26.9% |
| FY2017 | Dec 31, 2017 | $334.00K | -54.4% |
| FY2016 | Dec 31, 2016 | $733.00K | -50.4% |
| FY2015 | Dec 31, 2015 | $1.48M | -47.0% |
| FY2014 | Dec 31, 2014 | $2.79M | +1.7% |
| FY2013 | Dec 31, 2013 | $2.74M | -15.0% |
| FY2012 | Dec 31, 2012 | $3.23M | +16.1% |
| FY2011 | Dec 31, 2011 | $2.78M | +54.0% |
| FY2010 | Dec 31, 2010 | $1.81M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $34.00K | -74.4% |
| Q1 FY2026 | Mar 31, 2026 | $45.00K | -39.2% |
| Q4 FY2025 | Dec 31, 2025 | $127.00K | -9.3% |
| Q3 FY2025 | Sep 30, 2025 | $136.00K | +22.5% |
| Q2 FY2025 | Jun 30, 2025 | $133.00K | -40.1% |
| Q1 FY2025 | Mar 31, 2025 | $74.00K | +37.0% |
| Q4 FY2024 | Dec 31, 2024 | $140.00K | +62.8% |
| Q3 FY2024 | Sep 30, 2024 | $111.00K | +60.9% |
| Q2 FY2024 | Jun 30, 2024 | $222.00K | +236.4% |
| Q1 FY2024 | Mar 31, 2024 | $54.00K | +671.4% |
| Q4 FY2023 | Dec 31, 2023 | $86.00K | +120.5% |
| Q3 FY2023 | Sep 30, 2023 | $69.00K | +762.5% |
| Q2 FY2023 | Jun 30, 2023 | $66.00K | +633.3% |
| Q1 FY2023 | Mar 31, 2023 | $7.00K | -66.7% |
| Q4 FY2022 | Dec 31, 2022 | $39.00K | +129.4% |
| Q3 FY2022 | Sep 30, 2022 | $8.00K | -50.0% |
| Q2 FY2022 | Jun 30, 2022 | $9.00K | -55.0% |
| Q1 FY2022 | Mar 31, 2022 | $21.00K | +31.3% |
| Q4 FY2021 | Dec 31, 2021 | $17.00K | -22.7% |
| Q3 FY2021 | Sep 30, 2021 | $16.00K | -61.0% |
| Q2 FY2021 | Jun 30, 2021 | $20.00K | -63.6% |
| Q1 FY2021 | Mar 31, 2021 | $16.00K | -33.3% |
| Q4 FY2020 | Dec 31, 2020 | $22.00K | +144.4% |
| Q3 FY2020 | Sep 30, 2020 | $41.00K | +78.3% |
| Q2 FY2020 | Jun 30, 2020 | $55.00K | +27.9% |
| Q1 FY2020 | Mar 31, 2020 | $24.00K | -48.9% |
| Q4 FY2019 | Dec 31, 2019 | $9.00K | -87.0% |
| Q3 FY2019 | Sep 30, 2019 | $23.00K | -46.5% |
| Q2 FY2019 | Jun 30, 2019 | $43.00K | -30.6% |
| Q1 FY2019 | Mar 31, 2019 | $47.00K | -31.9% |
| Q4 FY2018 | Dec 31, 2018 | $69.00K | -16.9% |
| Q3 FY2018 | Sep 30, 2018 | $43.00K | -37.7% |
| Q2 FY2018 | Jun 30, 2018 | $62.00K | -30.3% |
| Q1 FY2018 | Mar 31, 2018 | $69.00K | -24.2% |
| Q4 FY2017 | Dec 31, 2017 | $83.00K | -60.1% |
| Q3 FY2017 | Sep 30, 2017 | $69.00K | -20.7% |
| Q2 FY2017 | Jun 30, 2017 | $89.00K | – |
| Q1 FY2017 | Mar 31, 2017 | $91.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $208.00K | – |
| Q3 FY2016 | Sep 30, 2016 | $87.00K | – |
See a number that looks wrong?